期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Crime against Humanity<br/>—Uncovering Two Decades of Corruption in the FDA Regarding DMD Treatment
1
作者 Peter K. Law 《Open Journal of Regenerative Medicine》 2017年第4期35-45,共11页
The world needs to know the facts as to how the FDA “protects” the public health by assuring the safety, effectiveness, and security of human drugs and biological products for human use. Recent uproar has surfaced o... The world needs to know the facts as to how the FDA “protects” the public health by assuring the safety, effectiveness, and security of human drugs and biological products for human use. Recent uproar has surfaced over the FDA’s approval process on the unproven Duchenne Muscular Dystrophy (DMD) drug, Exondys 51 (Sarepta Therapeutics, Cambridge, MA, USA), but what many people do not know are the unlawful events that occurred nearly two decades ago on a proven and promising treatment for DMD. 展开更多
关键词 FDA CORRUPTION DMD DUCHENNE Muscular DYSTROPHY exondys 51 MYOBLAST Transfer Therapy Peter K. Law Disqualification
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部